ARTH - Arch Therapeutics, Inc.
0
0.000 inf%
Share volume: 16,744
Last Updated: 12-23-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
-1.00%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 02-20-2024 | 05-09-2024 | 08-19-2024 | |
| Total revenue | 45.867 K | 31.866 K | 30.913 K | |
| Cost of revenue | 23.606 K | 21.555 K | 21.079 K | |
| Gross profit | 22.261 K | 10.311 K | 9.834 K | |
| -53.68% | -4.63% | |||
| Operating expenses | 1.517 M | 887.053 K | 1.031 M | |
| Selling general and admin | 1.311 M | 683.184 K | 875.629 K | |
| Research and development | 205.580 K | 203.869 K | 155.681 K | |
| Total expenses | 1.517 M | 887.053 K | 1.031 M | |
| -41.52% | 16.26% | |||
| Operating income | -1.495 M | -876.742 K | -1.021 M | |
| Ebit | -1.495 M | -876.742 K | -4.983 M | |
| Pretax income | -2.682 M | -1.469 M | -5.655 M | |
| -45.22% | 284.90% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -2.682 M | -1.469 M | -5.655 M | |
| 45.22% | -284.90% |